Leveraging AI and Social Media Analytics to Uncover Unreported Adverse Side Effects of GLP-1 Receptor Agonists

Social media data and advanced AI models can identify previously unreported adverse side effects of GLP-1 receptor agonists, a class of drugs used to treat obesity and type 2 diabetes.